[B3 Lesions of the Breast: Histological, Clinical, and Epidemiological Aspects : Update]
Overview
Authors
Affiliations
B3 lesions of the breast are a heterogeneous group of lesions with uncertain malignant potential encompassing a broad spectrum of histologically distinct alterations that often pose challenging decisions if diagnosed on the preoperative core or vacuum biopsies. B3 lesions are mostly detected due to mammographic calcifications or mass lesions and, in most cases, encompass a spectrum of atypical lesions such as atypical ductal hyperplasia, classic lobular neoplasia, flat epithelial atypia, papillomas, fibroepithelial tumors, and rarely other lesions such as mucocele-like lesions, atypical apocrine lesions, and rare stromal proliferations. The use of immunohistochemical stains (estrogen receptors, basal cytokeratin, myoepithelial markers, and stromal marker panel) is useful in the differentiation of these lesions and allowing proper classification. Regarding clinical management of B3 lesions, the radiological-pathological correlation of the given entity plays the most important key element for the proper next diagnostic and therapeutic step.
Heindl F, Schiel J, Hack C, Amann N, Jud S, Preuss C Breast Cancer Res Treat. 2025; .
PMID: 39960605 DOI: 10.1007/s10549-025-07632-7.
Nather S, Elfgen C, Rodewald A, Fansa H, Frauchiger-Heuer H, Varga Z J Cancer Res Clin Oncol. 2024; 150(9):436.
PMID: 39340595 PMC: 11438729. DOI: 10.1007/s00432-024-05934-9.
Park-Simon T, Muller V, Albert U, Banys Paluchowski M, Bauerfeind I, Blohmer J Breast Care (Basel). 2024; 19(3):165-182.
PMID: 38894952 PMC: 11182637. DOI: 10.1159/000538596.
Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools.
Varga Z, Maccio U Virchows Arch. 2023; 484(2):247-261.
PMID: 38015260 PMC: 10948467. DOI: 10.1007/s00428-023-03709-0.